News

Medical Dialogues14h
Itepekimab met primary endpoint in one of two COPD phase 3 studies: Sanofi, Regeneron
Paris: Sanofi has announced that the AERIFY-1 phase 3 study evaluating itepekimab in former smokers with inadequately ...
GB News on MSN19h
NHS Scotland launches AI trial to help detect lung cancer and strokes in X-rays - 'Huge potential!'
Two Scottish health boards are trialing a revolutionary artificial intelligence scanning of X-rays to detect signs of lung ...